Abstract Background: Assessment of clinical outcomes and patient quality of life after total hip arthroplasty continues to grow in importance with the focus on how bearing surfaces affect long-term survival, wear, and cost. Further, as quality measures have become incorporated into reimbursement, there is a need to quantify factors which may influence these outcomes. Currently, there is a paucity of literature regarding the effects of the femoral head composition on clinical outcomes or quality of life. Questions/Purposes: We sought to determine if any difference in quality of life measures could be detected in patients treated with total hip replacement implanted with cobalt-chrome (CoCr) versus ceramic femoral heads at 2-year follow-up. Methods: We compared the hip disability and osteoarthritis outcome score (HOOS) and EuroQOL (EQ5D) scores of a matched set of patients that underwent primary total hip arthroplasty with highly cross-linked polyethylene (HXLPE) and a single implant system consisting of either a metal or a ceramic femoral head. Results: Clinical outcomes and quality of life improved for both groups after hip replacement surgery. Patients with a ceramic head showed greater improvement than those with a metal head in HOOS pain and EQ5D VAS scores by a statistically significant margin (p=0.0417 and 0.019, respectively), but the differences between the HOOS and EQ5D VAS scores (3.4 and 0.04, respectively) do not demonstrate a clinically significant difference. Conclusions: We found that the femoral head composition has no effect on clinical outcomes or patient quality of life at 2 years.
Introduction
Both ceramic and cobalt-chrome are excellent materials for use in the femoral head of a total hip arthroplasty [1] . The choice between ceramic or cobalt-chrome often depends on wear properties, patient age, and head size. Little attention has been given to potential differences between the two femoral head choices regarding patient-reported outcomes and quality of life improvement. As programs such as the Physician Quality Reporting Initiative (PQRI) further incorporate these types of quality measures into reimbursement, the onus will be on the orthopedic community to determine which modifiable factors affect our quality outcomes.
We examined this question in patients that underwent total hip arthroplasty using a single-hip system with a second generation highly cross-linked polyethylene (HXLPE) liner and a femoral head composed of either cobaltchromium (CoCr) alloy or ceramic (Biolox Delta, Ceramtec AG). We hypothesized that all patients in this study cohort would demonstrate significant clinical and quality of life improvement after their total hip replacement and that these improvements would be independent of femoral head material composition. We specifically questioned whether a difference in (1) 2-year clinical outcomes as assessed by the hip disability and osteoarthritis outcome score (HOOS) and (2) patients' quality of life as assessed by the EuroQOL (EQ5D) could be detected after total hip arthroplasty implanting a cobalt-chrome versus ceramic femoral head.
Patients and Methods
The HSS/CERT Total Hip Replacement Registry (AHRQ #) is a prospective cohort of more than 8000 patients undergoing total hip arthroplasty at our institution. Preoperative, 6-month and 2-year demographic and clinical data are collected by questionnaire with an approximately 80% follow-up rate at both follow-up time points. The registry includes clinical outcomes data and patient satisfaction metrics, which are collected preoperatively and 2 years postoperatively. Information for the registry is collected with all considerations taken for the protection of human subjects and with the approval of the institution's IRB.
The database was queried for patients undergoing elective, unilateral, primary total hip replacements using components of a single manufacturer and a femoral head of either cobalt-chromium or ceramic (Stryker, Mahwah, NJ). At the time of this study, four surgeons in our institution were using this particular implant type. All of them were fellowship-trained joint replacement surgeons. All patients that matched these criteria were eligible for inclusion. Exclusion criteria eliminated any cases using a different implant system, to reduce the bias associated with multiple hip implants, as well as cases done in a non-elective fashion, such as for fracture, bilateral surgery, or revision surgery. Patients were also excluded if they did not have complete baseline and 2-year postoperative outcome data.
Propensity score matching method was used to create a ceramic head cohort and a metal head cohort which were balanced with respect to 12 baseline patient characteristics [9, 10] . Propensity score matching is a recommended method of controlling for the imbalances between cohorts. The propensity score was estimated using logistic regression to regress receipt of a Stryker ceramic head on age, sex, highest education level attained, BMI, ASA status, year of procedure, length of procedure, length of stay, Medicare insured, self-pay health insurance, discharge disposition, and pre-op lower extremity activity scale (LEAS) scores. Statistical analysis software (SAS) matching macro %GMATCH developed by Mayo clinic was adapted to complete the propensity score matching. One control was selected for each case without replacement using the greedy matching method, and a caliper width of 0.2 was specified to improve the quality of paired matches [9] . Initially, 235 ceramic and 422 metal single-sided primary total hip cases were eligible for inclusion. After taking into account the missing values of the covariates used for matching, 227 and 403 cases and controls were left. More cases and controls were excluded due to the non-overlapping distribution of the propensity scores during matching, leaving us with 146 patients in each group for a total effective sample size of 292 patients.
Standardized difference between the cases and controls was calculated in assessing balance in baseline variables after conditioning on the propensity scores. A standardized difference that is less than 0.1 has been taken to indicate a negligible difference in the mean or prevalence of variables between groups [8] .
The hip disability and osteoarthritis outcome score (HOOS) was chosen as the comparison tool as it has been demonstrated to be more responsive than Western Ontario and McMaster Universities Arthritis Index (WOMAC), especially in patients under the age of 66 [7] . The minimal clinically significant difference was set at 10, as this has been validated for the WOMAC, and has been previously applied to the HOOS [2] .
To determine improvement in quality of life, the EuroQOL (EQ5D) patient-reported outcome measure was chosen. This metric consists of five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain has three possible levels (i.e., 1, 2, or 3), representing "no problems," "some problems," and "extreme problems." EQ5D VAS scale ranges from 0 to 100. EQ5D index score (−0.59-1) is a summary score derived from the five domains. A higher score indicates a higher quality of life for the patient. Following the precedent set by the UK's National Institute for Health and Care Excellence (NICE), we used 0.074 as the minimal clinically significant difference for the EQ5D index score [4, 5] .
Descriptive statistics were calculated for baseline variables, preoperative, and 2-year postoperative outcomes. Means and standard deviations were calculated for continuous variables and frequencies and percentages for categorical variables. For inferential analysis, two-sample Student's t test was used for continuous measures, and categorical variables were compared using chi-square test or Fisher's exact test. Multiple linear regression analyses were performed to compare the postoperative HOOS scores for the matched metal head and ceramic head cohorts. A priori power analysis determined 81% power to detect a five-point difference in outcome scores, which is below the minimal detectable change (MDC) for the HOOS. Each model was performed both unadjusted and adjusted for the Charlson-Deyo comorbidity index and the propensity scores used for matching. Statistical analyses were performed using SAS for Windows 9.2 (SAS Institute Inc., Cary, NC, USA). All tests were two-sided and a critical p value of 0.05 was set for all comparisons.
Results
Two hundred ninety-two patients were identified that met inclusion criteria and were able to be matched appropriately. One hundred forty-six patients that received a CoCr femoral head were matched to 146 patients that received a ceramic head. A 32-mm CoCr femoral head costs $1214, while a 32-mm Biolox ceramic head costs $2644. The baseline characteristics used for matching all eligible patients are shown in Table 1 . The baseline characteristics utilized for matching the propensitymatched cohorts did not differ significantly (Table 2) . Similarly, the baseline characteristics that were not used for matching of the propensity-matched cohorts were not significantly different (Table 3) .
The HOOS scores were similar for the two groups preoperatively. Both groups demonstrated a substantial improvement in HOOS scores postoperatively. While the comparison between the two groups did demonstrate a statistically significant difference (p=0.0417) in HOOS pain score, this difference did not reach the level of clinical significance being only 3.4 points (Table 4) . Similarly, while the adjusted effect of femoral head composition on HOOS pain score was statistically significant, it was not clinically meaningful ( Table 5) .
The EQ5D scores were also similar for both groups preoperatively. Again, both groups treated with total hip (Table 4) . Again, the adjusted effect of femoral head composition on EQ5D VAS and composite scores were statistically significant but did not reach clinical significance (Table 5) .
Discussion
Cobalt-chrome on highly cross-linked polyethylene remains the gold standard for total hip replacement. The use of ceramic heads remains an attractive option in total hip replacement due to its potential for decreased long-term wear properties [11] . While these properties have been demonstrated in vitro and in vivo [1] , few previous studies have examined the implications of bearing choice on patient- reported clinical outcomes [6] and none have focused on quality-of-life metrics. Ceramic femoral heads have also been shown to be problematic, with reports of ceramic fracture even when coupled with a polyethylene bearing [3] . In this study, we attempted to determine whether our patients were achieving significant quality-of-life improvement after total hip arthroplasty and whether femoral head composition influenced clinical outcomes and quality-of-life improvement after total hip arthroplasty. We were able to demonstrate that regardless of femoral head bearing choice, all patients in this series who received a femoral stem from a single manufacturer and an XLPE acetabular liner demonstrated clinically and statistically significant improvements in both functional outcomes and quality of life at 2 years. Further, the data shows that the choice of femoral head material does not produce a clinically significant effect on these patient-reported outcomes at 2 year follow-up.
As with all studies, this study has several limitations. Firstly, as this is a retrospective study of patient-reported outcomes, there is an inherent level of follow-up bias. While our registry maintains an excellent follow-up rate for a registry of its size, any patients lost to follow up impart some level of bias. Another limitation is the lack of radiographic evaluation and complications data. Because of this, we cannot determine whether any component malposition or postoperative complications such as infection or dislocation have influenced clinical outcomes and thereby patient satisfaction. Thirdly, although 2-year follow-up is the standard requirement for joint replacement studies, it is questionable whether this is long enough to see true differences in outcomes based on head composition. We chose the 2-year time point for our study for three reasons. First, our arthroplasty registry collects data at the 2-year time point. Second, the 2-year time point is the most complete data set in our registry. Third, quality of life is a complex phenomenon, for which long-term study data is challenging to interpret since multiple factors in a patient's life can bias outcome scores. Further, the 2-year length of follow-up slightly complicates the cost discussion of this study, as the long-term costs associated with possibly differing wear rates may outweigh the benefits of the similar quality-of-life outcomes noted here.
This study also has certain strengths, including the evaluation of only a single system of hip stem and cup from a single manufacturer, which eliminates the variations that can been seen between arthroplasty systems. This was further strengthened by the use of only one acetabular bearing surface, in this case XLPE, from a single manufacturer, honing the comparison strictly on the femoral head composition. Also, strict matching criteria eliminated the bias of age and activity level often associated with studies of ceramic bearings in total hip arthroplasty. Finally, the use of validated patient-reported metrics strengthens our statistical analysis.
Recently, Nikolaou et al. published a prospective, randomized trial of alternative bearing surfaces for total hip replacement. They examined cobalt-chrome on UHMWPE, cobalt-chrome on XLPE, and ceramic on ceramic. At 5-year follow-up, no difference was found in the WOMAC, SF-12, or Harris hip scores of any of the groups [6] . The authors, however, made no mention of quality-of-life metrics.
Our data suggests that the choice of femoral head composition in total hip arthroplasty remains contingent on wear issues, and patient-reported quality metrics are not affected. As the medical field moves further into the era of reimbursement based on quality, these types of analyses become increasingly important to isolate variables associated with outcomes differences. This particular analysis carries additional value when deciding between options of similar outcomes [10] with varying cost.
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